Skip to main content
JAMA Network logoLink to JAMA Network
. 2022 Jan 5;7(3):341–345. doi: 10.1001/jamacardio.2021.5430

Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease

Vardhmaan Jain 1, Mahmoud Al Rifai 2, Rodman Turpin 3, Hatice Nur Eken 4, Ankit Agrawal 1, Dhruv Mahtta 2, Zainab Samad 5, Stephanie Coulter 6, Fatima Rodriguez 7, Laura A Petersen 8,9, Salim S Virani 2,9,10,
PMCID: PMC8733863  PMID: 34985497

Key Points

Question

Do sex-based differences exist in physical and mental health domains and health care access in adults with self-reported premature atherosclerotic cardiovascular disease (ASCVD)?

Findings

In this cohort study of 748 090 adults aged 18 to 55 years, 28 522 had self-reported premature ASCVD. Compared with men, women were more likely to report being clinically depressed, have cost-related medication nonadherence, have not seen a physician due to cost, and have overall poor physical health.

Meaning

Adults with premature ASCVD, especially women, may benefit from improved access to mental health services and interventions addressing out-of-pocket costs.


This cohort study evaluates the association of sex with physical and mental health domains as well as health care access–related factors among adults with self-reported premature atherosclerotic cardiovascular disease.

Abstract

Importance

There are limited data regarding sex-based differences in physical and mental health domains and health care access in adults with premature atherosclerotic cardiovascular disease (ASCVD).

Objective

To study the association of sex with physical and mental health domains as well as health care access–related factors among adults with self-reported premature ASCVD.

Design, Setting, and Participants

Retrospective cohort analysis of 748 090 adults aged 18 to 55 years in the Behavioral Risk Factor Surveillance System 2016 to 2019 in the US. Data were analyzed from June to July 2021.

Exposures

Self-reported ASCVD, defined as having a history of coronary artery disease, myocardial infarction, or stroke.

Main Outcomes and Measures

Self-reported physical and mental health and measures of health care access, including self-reported cost-related medication nonadherence and inability to see a physician due to cost.

Results

Between 2016 and 2019, 748 090 adults aged 18-55 years were identified, of whom 28 522 (3.3%) had self-reported premature ASCVD. Of these, 14 358 (47.0%) were women. Compared with men, women with premature ASCVD were more likely to report being clinically depressed (odds ratio [OR], 1.73; 95% CI, 1.41-2.14; P < .001), have cost-related medication nonadherence (OR, 1.42; 95% CI, 1.11-1.82; P = .005), have not seen a physician due to cost-related issues (OR, 4.52; 95% CI, 2.24-9.13; P < .001), and were more likely to report overall poor physical health (OR, 1.39; 95% CI, 1.09-1.78; P = .008) despite being more likely to have health care coverage (85.3% vs 80.8%; P = .04) and a primary care physician (84.2% vs 75.7%; P < .001).

Conclusions and Relevance

Results from this study indicate that women with premature ASCVD were more likely to report worse overall physical and mental health, inability to see a physician due to cost, and cost-related medical nonadherence. Interventions addressing mental health and out-of-pocket costs are needed in adults with premature ASCVD.

Introduction

Atherosclerotic cardiovascular disease (ASCVD) among young adults is a public health challenge with a worldwide prevalence of 10% to 30%.1 Despite having higher rates of hospitalization for symptomatic ASCVD, women are less likely to receive guideline-directed treatment,2 antiplatelet therapy, and statin therapy and have lower statin adherence compared with men.3 As a result, women with premature ASCVD are more likely to have worse overall outcomes.4 Further, poor mental health, medication nonadherence, and lack of health care access have been associated with poor control of cardiovascular risk factors as well as increased risk of ASCVD events.5,6,7,8 Therefore, it is important to determine the extent to which sex-based differences exist in health care access and socioeconomic and mental health–related factors among men and women with premature ASCVD.

We investigated the association of sex with physical and mental health domains, as well as health care access–related factors, including cost-related medication nonadherence and inability to see a physician due to cost among adults with premature ASCVD.

Methods

The Behavioral Risk Factor Surveillance System (BRFSS) survey from 2016 to 2019 was used to identify adults aged 18 to 55 years. As BRFSS is a deidentified database, the study was exempt from institutional review board approval, and consent was not required. The presence of cardiovascular comorbidities, including hypertension, dyslipidemia, diabetes, and chronic kidney disease, were self-reported. ASCVD status was ascertained by participants responding to the question “Have you ever had coronary heart disease or myocardial infarction or stroke?” Adults aged 18 to 55 years who answered yes to the above question were considered as having self-reported premature ASCVD.

Physical and mental health domains, sex, race and ethnicity, and medication adherence were self-reported. Details regarding these questions are provided in eTable 1 in the Supplement. The estimates provided by the BRFSS questionnaire, including data on self-reported ASCVD, have been previously validated against other national estimates.9,10

We analyzed these cross-sectional data using survey weights for BRFSS provided by the US Centers for Disease Control and Prevention. We performed multivariable logistic regression analyses to study the association of sex with physical and mental health domains as well as health care access–related factors among adults with premature ASCVD. Regression models were adjusted for age, race and ethnicity, education, employment, relation to poverty line, and rural residence.

Results

Our study population included 748 090 participants between the ages of 18 and 55 years, of whom 28 522 (3.3%) reported a history of ASCVD. The baseline characteristics of the overall cohort and those with self-reported premature ASCVD stratified by sex are listed in Table 1. Women with premature ASCVD were more often Black, had lower income levels, and were less likely to report hypertension, hyperlipidemia, and diabetes. Women were also less likely to have received emotional support, be dissatisfied with their quality of life, and report higher levels of depression compared with men with premature ASCVD. They were more likely to report an inability to see a physician due to cost and cost-related medication nonadherence, despite being more likely to have health care coverage and a primary care physician. Compared with the overall cohort, both men and women with premature ASCVD were more likely to report an inability to see a physician due to cost, cost-related medication nonadherence, overall worse physical health, clinical depression, and lower levels of emotional support (Table 1).

Table 1. Baseline and Demographic Characteristics of the Overall Cohort and Adults With Premature Atherosclerotic Cardiovascular Disease (ASCVD) Stratified by Sex.

Characteristica Overall cohort Individuals with premature ASCVD
No. (%) P value No. (%) P value
Male Female Male Female
No. (%) 359 203 (50.3) 393 679 (49.7) NA 14 119 (53.0) 14 358 (47.0) NA
Age group, y
18-34 143 810 (48.4) 138 171 (46.9) <.001 1952 (18.8) 1868 (20.4) .06
35-44 93 670 (25.7) 109 119 (26.3) 3019 (25.5) 3435 (27.0)
45-54 121 723 (25.8) 146 389 (26.9) 9148 (55.6) 9055 (52.6)
Race and ethnicityb
Non-Hispanic Black 28 165 (11.9) 40 407 (13.9) <.001 1389 (14.7) 2039 (18.1) <.001
Hispanic 46 751 (21.4) 53 104 (21.1) 1742 (19.9) 1861 (20.7)
Non-Hispanic White 240 181 (56.7) 259 290 (55.2) 8975 (56.4) 8740 (53.3)
Otherc 36 249 (10.1) 34 716 (9.9) 1652 (8.9) 1414 (7.8)
Education
<High school 28 387 (13.7) 27 118 (12.0) <.001 2180 (26.1) 2009 (22.3) <.001
High school or college 201 636 (60.4) 203 950 (57.3) 8684 (58.7) 9014 (61.8)
>College 127 499 (25.9) 161 264 (30.7) 3181 (15.2) 3279 (15.8)
Annual income, $
<10 000 13 318 (4.8) 21 210 (7.3) <.001 1422 (12.2) 2021 (16.9) <.001
10 000-14 999 10 251 (3.5) 15 791 (5.1) 1130 (8.9) 1412 (10.9)
15 000-19 999 17 660 (6.2) 24 791 (8.2) 1427 (11.9) 1619 (12.8)
20 000-24 999 22 958 (8.3) 29 234 (9.4) 1354 (11.4) 1514 (14.0)
25 000-34 999 27 468 (9.4) 31 421 (9.8) 1183 (10.7) 1257 (10.6)
35 000-49 999 39 853 (12.9) 41 090 (12.0) 1272 (10.4) 1253 (9.9)
50 000-74 999 49 754 (15.2) 50 239 (13.9) 1439 (10.8) 1156 (9.3)
≥75 000 125 516 (39.8) 120 541 (34.3) 2818 (23.7) 1897 (15.6)
Relation to poverty line
Below poverty line 38 602 (13.3) 62 534 (19.3) <.001 3246 (26.7) 4367 (32.9) <.001
Within 100%-200% 60 919 (18.3) 71 294 (18.8) 3256 (22.9) 3474 (24.4)
>200% 239 609 (68.5) 240 765 (62.0) 6843 (50.4) 5821 (42.7)
Body mass indexd
Underweight 4613 (1.6) 7519 (2.7) <.001 179 (1.1) 334 (2.7) .21
Normal weight 95 614 (30.4) 128 525 (39.2) 2626 (21.3) 3136 (26.1)
Overweight 132 738 (38.8) 95 972 (27.5) 4451 (33.9) 3325 (25.2)
Obese 105 353 (29.2) 112 152 (30.6) 6016 (43.8) 6035 (46.1)
Hypertension 44 323 (22.7) 35 144 (15.8) <.001 4288 (64.0) 3657 (51.3) <.001
Hyperlipidemia 35 349 (22.1) 34 393 (18.3) <.001 3482 (55.5) 3073 (46.5) <.001
Diabetes 21 311 (5.3) 23 937 (5.4) .31 3436 (23.6) 3525 (21.4) <.001
Chronic kidney disease 5291 (1.4) 7831 (1.8) <.001 1201 (8.7) 1446 (9.5) .21
Current smoking 67 662 (19.0) 64 193 (14.6) <.001 4629 (32.2) 4740 (30.8) <.001
Current e-cigarette use 15 894 (10.7) 11 264 (5.8) <.001 730 (12.0) 722 (9.7) <.001
Use of other tobacco products 31 780 (7.8) 4179 (1.1) <.001 1469 (10.6) 303 (2.2) .04
Marijuana use 9622 (17.0) 6140 (10.7) <.001 406 (16.5) 299 (11.7) .70
Heavy alcohol consumptione 19 548 (7.7) 18 487 (6.4) <.001 819 (8.5) 496 (4.9) .46
Have health care coverage 302 148 (81.9) 346 155 (85.4) <.001 11 777 (80.8) 12 445 (85.3) .04
Have a primary care physician 232 756 (62.5) 312 594 (75.9) <.001 11 039 (75.7) 12 429 (84.2) <.001
Rural county resident 20 867 (19.6) 32 752 (19.2) .23 1162 (22.7) 1487 (23.7) .57
Residing in a state with Medicaid expansion 270 916 (69.0) 292 124 (68.7) .15 10 057 (65.1) 9992 (65.2) .91
Overall health
Excellent 74 767 (21.6) 77 918 (20.0) <.001 866 (6.4) 718 (5.4) <.001
Very good 123 625 (33.2) 134 155 (32.7) 2055 (13.8) 1781 (11.8)
Good 112 475 (31.7) 120 106 (31.9) 4392 (32.0) 3918 (28.5)
Fair 36 962 (10.8) 46 161 (12.0) 4086 (29.7) 4628 (32.9)
Poor 10 612 (2.8) 14 736 (3.4) 2669 (18.3) 3269 (21.5)
Access to emotional support when needed
Always 5560 (54.3) 5889 (51.6) <.001 149 (46.9) 129 (44.0) .47
Usually 2568 (24.9) 3192 (28.6) 77 (22.3) 61 (20.2)
Sometimes 1131 (12.3) 1237 (13.7) 59 (17.1) 56 (21.6)
Rarely 326 (3.8) 341 (3.7) 13 (4.7) 24 (8.7)
Never 444 (4.8) 243 (2.5) 30 (9.1) 23 (5.6)
Overall satisfaction with life
Very satisfied 4671 (45.7) 5214 (44.9) .22 109 (34.3) 80 (23.2) .04
Satisfied 4872 (48.0) 5125 (49.4) 174 (51.6) 149 (54.8)
Dissatisfied 457 (5.1) 439 (4.3) 35 (11.9) 43 (14.2)
Very dissatisfied 109 (1.1) 129 (1.4) 10 (2.2) 23 (7.8)
Self-perceived good physical health 242 377 (68.2) 237 210 (61.5) <.001 5545 (39.9) 4176 (30.7) <.001
Unable to see a physician due to cost 2340 (8.9) 4320 (13.2) <.001 318 (24.6) 450 (33.8) <.001
Cost-related medication nonadherence 2340 (14.2) 4320 (18.1) <.001 3690 (27.8) 4325 (32.5) <.001
Clinical depression 53 183 (13.6) 102 146 (24.1) <.001 4973 (34.1) 7366 (50.0) <.001

Abbreviation: NA, not applicable.

a

All data in the table were self-reported.

b

Race and ethnicity were determined by response to a multiple choice question asked by the interviewer. Available options included non-Hispanic American Indian/Alaskan Native, non-Hispanic Asian, non-Hispanic Black or African American, Hispanic, and non-Hispanic White.

c

Includes non-Hispanic Asian and non-Hispanic American Indian/Alaskan Native, consolidated owing to low numbers.

d

Calculated as weight in kilograms divided by height in meters squared.

e

Heavy alcohol consumption was defined as adult men consuming more than 14 drinks per week and adult women consuming more than 7 drinks per week. One drink is equivalent to 12 oz of beer, 5 oz of wine, or 1.5 oz of liquor.

After multivariable logistic regression, women with premature ASCVD were more likely to report overall poor physical health (odds ratio [OR], 1.39; 95% CI, 1.09-1.78; P = .008), clinical depression (OR, 1.73; 95% CI, 1.41-2.14; P < .001), cost-related medication nonadherence (1.42; 95% CI, 1.11-1.82; P = .005), and inability to see a physician due to cost related issues (OR, 4.52; 95% CI, 2.24-9.13; P < .001) compared with men with premature ASCVD (Table 2). Directionally similar results were observed in the sensitivity analyses stratified by race and ethnicity and among adults with very premature ASCVD (eTable 2 in the Supplement).

Table 2. Odds Ratios (ORs) for the Prevalence of Care Delivery–Associated Risk Factor Profile and Indicators of Physical and Mental Well-being for Women vs Men (Reference Men).

Risk factor Unadjusted Adjusteda
OR (95% CI) P value OR (95% CI) P value
Self-reported poor physical health 1.50 (1.35-1.66) <.001 1.39 (1.09-1.78) .008
Self-reported clinical depression 1.93 (1.75-2.12) <.001 1.73 (1.41-2.14) <.001
Self-reported poor general health 1.22 (1.10-1.37) <.001 1.22 (0.95-1.57) .11
Self-reported having never received emotional support 0.59 (0.23-1.53) .28 0.36 (0.10-1.31) .12
Self-reported inability to see physician due to cost 1.56 (1.13-2.14) <.001 4.52 (2.24-9.13) <.001
Self-reported cost-related medication nonadherence 1.24 (1.12-1.38) <.001 1.42 (1.11-1.82) .005
a

Model adjusted for age, race and ethnicity, employment, education, relation to poverty line, and rural residence.

Discussion

Using data from a large nationally representative population, we found that women with premature ASCVD were more likely to report worse physical and general health and higher levels of clinical depression compared with their male counterparts. Despite having higher rates of health care coverage, women were more likely to have not seen a physician due to cost related concerns and to have cost-related medication nonadherence. These findings suggest that while women might be more likely to seek routine care, they may face barriers to accessing this care.

Prior studies have shown that despite having a significant number of cardiac risk factors, most young women may not believe that they are at risk of heart disease, such that they are less likely to discuss primary prevention strategies with their treating clinicians.11 We found that despite having a primary care physician and health care coverage, women were more likely to have cost-related barriers to health care access. Women were also more likely to report lower income and to be below the federal poverty line. Thus, despite having health care coverage, it may be more difficult for women to see a clinician or take a prescribed medication compared with men because of copays or other expenses. With new therapies emerging, the cost of medication is expected to increase, which may worsen unaddressed disparities. Further, women have been shown to have higher rates of dissatisfaction with the health care system in the setting of poor patient-physician communication,12 which may discourage them further from seeing their physicians.

Our study also indicates that women with established ASCVD were more likely to be clinically depressed and report worse overall physical health, general health, and lower levels of emotional support and satisfaction with life. Although not available for ascertainment in BRFSS, it is possible that this sex disparity among patients with ASCVD could be a reflection of the extra burden that young women with ASCVD carry in terms of caring for their families (children and parents) compared with men.13,14 Addressing mental well-being as an integral part of management of ASCVD in young adults is of paramount importance. Clinicians should incorporate mental well-being screening in all visits for cardiovascular care, and families need to be supportive and dissuade patients with premature ASCVD from associating any stigma surrounding mental health issues. We believe that, apart from therapeutic inertia on the part of clinicians treating patients with premature ASCVD, social determinants also differentially impact women with premature ASCVD more often than men, further exaggerating these disparities in both receiving evidence-based therapies and adherence to those therapies.

We also report that, compared with the overall cohort, both men and women with premature ASCVD were more likely to report an inability to see a physician due to cost, cost-related medication nonadherence, overall worse physical health, clinical depression, and lower levels of emotional support (Table 1). Thus, adults with premature ASCVD in general constitute a vulnerable population. Our results aligns well with those of recent reports of higher cardiovascular mortality in socially vulnerable groups.15 These findings underscore the importance of narrowing cardiovascular disparities by encouraging policy-level efforts that advocate for integrating social determinants of health into existing clinical delivery support systems and promote investments in developing social risk assessment tools that enable physicians to specifically target this vulnerable population. Lastly, our results highlight the need for policy-level interventions to address out-of-pocket costs for this young patient population.

Our results must be interpreted in the context of certain limitations. This was a cross-sectional study, and therefore causality and directionality cannot be inferred. As information was self-reported, it is subject to measurement error and response bias. Whether poor physical and mental health was present before the diagnoses if ASCVD or developed as a result of ASCVD cannot be ascertained by our data. It is also noteworthy that participants with self-reported reduced health status may be selectively driving our findings, and our results could be reflective of this bias.

In conclusion, patients with premature ASCVD, especially women, are more likely to report worse overall physical and mental health, an inability to see a physician due to cost, and cost-related medical nonadherence. Interventions addressing mental health and out-of-pocket costs are needed in adults with premature ASCVD.

Supplement.

eTable 1. Data variables and corresponding questions asked to the participants as a part of the Behavioral Risk Factor Surveillance System questionnaire

eTable 2. Odds ratios for the prevalence of care delivery related risk factor profile, as well as indicators of physical and mental well-being for women vs men (reference men) among those with premature ASCVD (stratified by race) and among those with very premature ACVD

References

  • 1.Mahtta D, Khalid U, Misra A, Samad Z, Nasir K, Virani SS. Premature atherosclerotic cardiovascular disease: what have we learned recently? Curr Atheroscler Rep. 2020;22(9):44. doi: 10.1007/s11883-020-00862-8 [DOI] [PubMed] [Google Scholar]
  • 2.Arora S, Stouffer GA, Kucharska-Newton AM, et al. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139(8):1047-1056. doi: 10.1161/CIRCULATIONAHA.118.037137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lee MT, Mahtta D, Ramsey DJ, et al. Sex-related disparities in cardiovascular health care among patients with premature atherosclerotic cardiovascular disease. JAMA Cardiol. 2021;6(7):782-790. doi: 10.1001/jamacardio.2021.0683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Vikulova DN, Grubisic M, Zhao Y, et al. Premature atherosclerotic cardiovascular disease: trends in incidence, risk factors, and sex-related differences, 2000 to 2016. J Am Heart Assoc. 2019;8(14):e012178. doi: 10.1161/JAHA.119.012178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Okunrintemi V, Valero-Elizondo J, Michos ED, et al. Association of depression risk with patient experience, healthcare expenditure, and health resource utilization among adults with atherosclerotic cardiovascular disease. J Gen Intern Med. 2019;34(11):2427-2434. doi: 10.1007/s11606-019-05325-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004;66(3):305-315. doi: 10.1097/01.psy.0000126207.43307.c0 [DOI] [PubMed] [Google Scholar]
  • 7.Brooks EL, Preis SR, Hwang SJ, et al. Health insurance and cardiovascular disease risk factors. Am J Med. 2010;123(8):741-747. doi: 10.1016/j.amjmed.2010.02.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-186. doi: 10.1001/jama.297.2.177 [DOI] [PubMed] [Google Scholar]
  • 9.Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health. 2003;93(8):1335-1341. doi: 10.2105/AJPH.93.8.1335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pierannunzi C, Hu SS, Balluz L. A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011. BMC Med Res Methodol. 2013;13:49. doi: 10.1186/1471-2288-13-49 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Leifheit-Limson EC, D’Onofrio G, Daneshvar M, et al. Sex differences in cardiac risk factors, perceived risk, and health care provider discussion of risk and risk modification among young patients with acute myocardial infarction: the VIRGO Study. J Am Coll Cardiol. 2015;66(18):1949-1957. doi: 10.1016/j.jacc.2015.08.859 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Okunrintemi V, Valero-Elizondo J, Patrick B, et al. Gender differences in patient-reported outcomes among adults with atherosclerotic cardiovascular disease. J Am Heart Assoc. 2018;7(24):e010498. doi: 10.1161/JAHA.118.010498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Abed MA, Kloub MI, Moser DK. Anxiety and adverse health outcomes among cardiac patients: a biobehavioral model. J Cardiovasc Nurs. 2014;29(4):354-363. doi: 10.1097/JCN.0b013e318292b235 [DOI] [PubMed] [Google Scholar]
  • 14.Lett HS, Blumenthal JA, Babyak MA, et al. Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol. 2007;26(4):418-427. doi: 10.1037/0278-6133.26.4.418 [DOI] [PubMed] [Google Scholar]
  • 15.Khan SU, Javed Z, Lone AN, et al. Social vulnerability and premature cardiovascular mortality among US counties, 2014 to 2018. Circulation. 2021;144(16):1272-1279. doi: 10.1161/CIRCULATIONAHA.121.054516 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement.

eTable 1. Data variables and corresponding questions asked to the participants as a part of the Behavioral Risk Factor Surveillance System questionnaire

eTable 2. Odds ratios for the prevalence of care delivery related risk factor profile, as well as indicators of physical and mental well-being for women vs men (reference men) among those with premature ASCVD (stratified by race) and among those with very premature ACVD


Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES